Navigating Post-Covid Diligence Issues in M&A Transactions
The COVID-19 pandemic and the accompanying market downturn have resulted in widespread uncertainty felt on a global scale – including in the M&A space. This webinar explored ways M&A transactions – particularly due diligence and related deal terms – have changed in the wake of the pandemic and how buyers and sellers can adapt their respective approaches to the critical due diligence step of a transaction.
Travel restrictions, pandemic-related “stress test” analyses, and limited accessibility to key assets have already had a significant impact on the due diligence process, including the need to extend exclusivity periods and provide buyers with better visibility into a seller’s pre and post-COVID performance. An analyses of these considerations, as well as the need to address a target company’s legal, regulatory, human resources, insurance, financial, and operational soundness in light of COVID-19 will be discussed.
While this webinar covered these issues applicable to various industries, the presenters highlighted how such matters translate for technology-focused companies and investors.
This presentation was recorded and current as of September 24, 2020. Content viewed after this date may no longer be current.
This information is provided by Vinson & Elkins LLP for educational and informational purposes only and is not intended, nor should it be construed, as legal advice.